Table 4.

Correlation Analysis Between Lipoproteins and CTA‐Derived Quantitative Coronary Atherosclerotic Plaque Parameters.

	Biomarker	Univariate r Value	Univariate P Value	Multivariable β‐Coefficient	Multivariable P Value	Adjusted P Value
CAP Volume	Pre‐α3‐HDL	−0.28	0.05	−8.36	0.12	0.12
	Pre‐β2‐HDL%	−0.29	0.04	−24.65	0.02	0.02
	Pre‐β2‐HDL	−0.29	0.04	−16.66	0.02	0.02
CAP%	Pre‐α4‐HDL	−0.28	0.04	−4.14	0.24	0.24
	Pre‐α4‐HDL%	−0.28	0.05	−7.14	0.13	0.13
	TC	−0.29	0.04	−0.02	0.77	0.77
	sd‐LDL	−0.30	0.03	−0.31	0.19	0.19
	ApoB	−0.33	0.02	−0.08	0.47	0.47
	Pre‐α3‐HDL	−0.37	<0.01	−2.93	0.03	0.03
	Pre‐α3‐HDL%	−0.37	<0.01	−4.4	0.01	0.01
HD‐NCP%	Pre‐α3‐HDL	0.40	<0.01	2.98	0.01	0.01
	Pre‐α3‐HDL%	0.39	<0.01	4.32	<0.01	<0.01
	ApoB	0.31	0.03	0.07	0.46	0.46
	sd‐LDL	0.3	0.03	0.3	0.17	0.17
	Pre‐α4‐HDL	0.29	0.04	3.99	0.21	0.21
	TC	0.27	0.05	0.02	0.76	0.76
LD‐NCP%	Triglycerides	0.34	0.01	0.01	0.18	0.18
	Α3‐HDL%	0.32	0.02	0.12	0.10	0.10
	ApoB	0.29	0.04	0.01	0.7	0.7
	TC	0.24	0.08	0	0.91	0.91
	HDL‐C	−0.34	0.01	−0.1	0.07	0.07
	A2‐HDL%	−0.34	0.02	−0.16	0.12	0.12
	A1‐HDL%	−0.28	0.05	−0.12	0.20	0.20
MLA	Lp(a)	0.27	0.05	0.02	0.08	0.08
%AS	Lp(a)	−0.14	0.31	−0.05	0.64	0.64
	Pre‐α2‐HDL	−0.30	0.03	−1.17	0.23	0.23
MLD	Lp(a)	0.23	0.10	0	0.32	0.32
	Pre‐α2‐HDL	0.04	0.77	−0.03	0.28	0.28
	Pre‐β2‐HDL%	0.30	0.03	0.21	0.02	0.02
%DS	Pre‐α2‐HDL%	−0.28	0.05	−1.33	0.32	0.32
	Pre‐α3‐HDL	−0.29	0.04	−1.88	0.11	0.11
	Pre‐β2‐HDL	−0.30	0.03	−3.27	0.04	0.04

Adjusted P values represent adjusting for age, sex, BMI, diabetes, and medication use. One multivariable model was fit for each biomarker separately. AS indicates area stenosis; BMI, body mass index; CAP, calcified plaque; CTA, computed tomography angiography; DS, diameter stenosis; HDL, high‐density lipoprotein; HD‐NCP, high‐density noncalcified plaque; LD‐NCP, low‐density noncalcified plaque; Lp(a), lipoprotein a; MLA, minimal luminal area; MLD, minimal lumen diameter; sd‐LDL, small, dense low‐density lipoprotein; TC, total cholesterol.